Nicholson Nur
SEC insider (Form 3/4/5 filer). CIK 0001827317. Chief Technology Officer at Kailera Therapeutics, Inc. (KLRA) and 1 other issuer. 24 reported Form 4/5 transactions since Sep 2024; latest on Sep 7, 2026. Located in WALTHAM, MA.
Companies Nicholson Nur has filed insider reports for
- Kailera Therapeutics, Inc. (KLRA): Officer, Chief Technology Officer
- Apellis Pharmaceuticals, Inc. (APLS): Officer, Chief Technical Officer
Nicholson Nur
CIK: 0001827317
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Sep 7, 2026KLRA
Kailera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
220K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect22.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect41.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect45.2K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect24.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect24.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect45.2K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect41.3K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect5.6K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
AwardDirect22.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 7, 2026 |  KLRA Kailera Therapeutics, Inc. | Award Stock Option (right to buy) | 220,000 | - | - | Direct |
| May 14, 2026 |  APLS Apellis Pharmaceuticals, Inc. | Disposition | 22,610 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 41,250 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 45,220 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 24,284 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 24,284 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 45,220 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 41,250 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 5,645 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Award | 22,610 | - | $0 | Direct |
1-10 of 24 transactions